This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) slipped 8.94% to $302.42 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.47% to 14,501.91 and the Dow Jones Industrial Average rising 0.30% to 34,416.99. Moderna Inc. closed $195.07 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (ABBV) fell 0.17% to $109.32, Amgen Inc. (AMGN) fell 0.89% to $209.98, and AstraZeneca PLC ADR (AZN.LN) fell 0.05% to $59.86. Trading volume (17.1 M) remained 330,279 below its 50-day average volume of 17.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2021.
(END) Dow Jones Newswires
October 06, 2021 16:31 ET (20:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.